Effective treatment of kaposiform hemangioendotheliomas associated with Kasabach-Merritt phenomenon using four-drug regimen

Keyphrases

• Effective Treatment 100%
• Kaposiform Hemangioendothelioma 100%
• Kasabach-Merritt 100%
• Drug Regimen 100%
• Tumor 33%
• Remission 33%
• Clinical Conditions 33%
• Life-threatening 33%
• Interferon-α (IFN-α) 33%
• Progressive Development 33%
• Antiproliferative Activity 33%
• Chest Wall 33%
• Methotrexate 33%
• Cyclophosphamide 33%
• Critically Ill Patients 33%
• Actinomycin D 33%
• Antiangiogenic 33%
• Cortisone 33%
• Stopping Therapy 33%
• Consumption Coagulopathy 33%

Pharmacology, Toxicology and Pharmaceutical Science

• Kasabach Merritt Syndrome 100%
• Hemangioendothelioma 100%
• Dactinomycin 33%
• Antiangiogenic 33%
• Disseminated Intravascular Clotting 33%
• Remission 33%
• Alpha Interferon 33%
• Methotrexate 33%
• Cyclophosphamide 33%
• Neoplasm 33%
• Vincristine 33%
• Cortisone 33%